Login / Signup

Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer.

Mehdi GhahartarsFatemeh SedaghatElham KhajaviAmir Ali NejatMahyar MalekzadehAbbas GhaderiMohammad Javad Fattahi
Published in: Dermatology research and practice (2021)
According to our results, it can be concluded that IL-17A may play a role in inducing the growth and progression of NMSC and it can be used as a therapeutic target in these patients in future.
Keyphrases
  • skin cancer
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • current status